Biolase Inc Cmn (BIOL) 1.13 $BIOL
BIOLASE Reports 2016 Second Quarter and Six-Month Results
BusinessWire - 2 hrs 9 mins ago
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the second quarter and six months ended June 30, 2016.
BIOL: 1.13 (-0.03)
BIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement
BusinessWire - 2 hrs 19 mins ago
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that investors, including the Jack W. Schuler Living Trust, Oracle Partners, L.P. and Oracle Institutional Partners L.P., and certain BIOLASE directors and officers, have agreed to purchase $10 million of unregistered shares of the Company's convertible preferred stock, and related warrants to purchase unregistered shares of the Company's common stock, in a private placement transaction.
BIOL: 1.13 (-0.03)
BIOLASE(R) to Host 2016 Second Quarter Financial Results Conference Call on August 1
BusinessWire - Mon Jul 25, 5:00AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, August 1, 2016 at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter and six months ended June 30, 2016, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.
BIOL: 1.13 (-0.03)
BIOLASE to Present at the LD Micro Invitational
ACCESSWIRE - Wed Jun 01, 5:00AM CDT
LOS ANGELES, CA / ACCESSWIRE / June 1, 2016 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 6th annual LD Micro Invitational investor conference in Track 1 at 12:30 PM PDT, Wednesday, June 8, 2016. BIOLASE Senior Vice President and Chief Financial Officer David Dreyer will be giving the presentation and meeting with investors.
BIOL: 1.13 (-0.03)
Biolase reports 1Q loss
Automated Insights - Mon May 09, 4:02PM CDT
IRVINE, Calif. (AP) _ Biolase Inc. (BIOL) on Monday reported a loss of $4.3 million in its first quarter.
BIOL: 1.13 (-0.03)
BIOLASE Reports 2016 First Quarter Results
BusinessWire - Mon May 09, 3:05PM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the first quarter ended March 31, 2016.
BIOL: 1.13 (-0.03)
BIOLASE(R) to Host 2016 First Quarter Financial Results Conference Call on May 9, 2016
BusinessWire - Mon May 02, 5:00AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, May 9, 2016 at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2016, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.
BIOL: 1.13 (-0.03)
BIOLASE Reports 2015 Fourth Quarter and Year-End Results
BusinessWire - Wed Mar 09, 3:05PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the fourth quarter and year ended December 31, 2015.
BIOL: 1.13 (-0.03)
BIOLASE signs dental laser products development agreement with IPG Photonics
M2 - Thu Jan 14, 7:30AM CST
Dental lasers company BIOLASE (NasdaqCM:BIOL) revealed on Wednesday that it has entered into a development and distribution agreement with IPG Medical for dental laser products.
BIOL: 1.13 (-0.03), IPGP: 84.29 (+0.04)
BIOLASE Enters Into Development Agreement with IPG Photonics
BusinessWire - Tue Jan 12, 3:05PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it recently entered into a development and distribution agreement with IPG Photonics Corporation's medical laser division, IPG Medical.
BIOL: 1.13 (-0.03), IPGP: 84.29 (+0.04)
Refractive Surgery Devices Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Wed Dec 23, 6:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/d7svhj/refractive) has announced the addition of the "Refractive Surgery Devices - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Refractive Surgery Devices pipeline products. Key Topics Covered: - Extensive coverage of the Refractive Surgery Devices under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Refractive Surgery Devices and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Refractive Surgery Devices under development - Develop market-entry and market expansion strategies Companies Mentioned: - Alcon, Inc. - Avedro, Inc. - Belkin Laser Ltd - Biolase, Inc. - Carl Zeiss Meditec AG - CV Laser Pty Ltd - IFS Construction Services Ltd - Lensar, Inc. - Massachusetts Eye and Ear Infirmary - Nidek Co., Ltd. - Oraya Therapeutics, Inc. - Princeton University - Rowiak GmbH - Spire Corporation - STAAR Surgical Company - Stroma Medical Corp - Technolas Perfect Vision GmbH (Inactive) - University of Bern - University of Calgary - Visioneering Technologies, Inc. - Wake Forest Baptist Medical Center Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Refractive Surgery Devices - Pipeline Products under Development by Companies 5 Refractive Surgery Devices Companies and Product Overview 6 Refractive Surgery Devices- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/d7svhj/refractive
STAA: 6.84 (+0.08), BIOL: 1.13 (-0.03)
World Cosmetic Dentistry Market 2015-2020 - Dental Implants, Bridges, Crowns, Orthodontic Braces, Lasers, Veneers, Handpieces, Bonding Agents, Chairs & CAD/CAM
M2 - Mon Dec 07, 5:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/zfmwlq/cosmetic) has announced the addition of the "Cosmetic Dentistry Market by Product (Dental Implants, Dental Bridges, Dental Crowns, Orthodontic Braces, Dental Lasers, Dental Veneers, Dental Handpieces, Bonding Agents, Dental Lasers, Dental Chairs, CAD/CAM Systems) - Global Forecast to 2020" report to their offering. The Global Cosmetic Dentistry Market is Estimated to Grow at a CAGR of 6.8% from 2015 to 2020 to Reach USD 22.4 Billion by 2020 Growing consumer awareness, rising focus on dental aesthetics, expanding middle-class population with increasing disposable incomes in developing nations, and rising dental tourism in emerging markets are the major factors driving the growth of the cosmetic dentistry market. With rising focus on technological innovations and the increasing trend of R&D investments, various new products such as dental implants and equipment are being launched in Cosmetic Dentistry market, which are expected to further propel market growth. However, a lack of reimbursements for cosmetic dental procedures and the high cost of dental imaging systems could restrain the growth of this market during the forecast period. In this report, the cosmetic dentistry market is segmented on the basis of product and region. On the basis of products, Cosmetic Dentistry market is segmented into dental implants, dental bridges, dental crowns, dental veneers, dental systems and equipment, orthodontic braces, bonding agents, and inlays and onlays. Of these, the dental systems and equipment market accounted for the largest share in 2014, owing to the wide applications of dental equipment such as dental chairs, handpieces, and CAD/CAM systems in dental procedures. Geographically, the global cosmetic dentistry market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2014, Europe commanded a major share of the cosmetic dentistry market; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to improvements in healthcare infrastructure, rising disposable incomes, and increasing dental tourism in this region. Some prominent players in this market include - 3M Company - A-Dec Inc. - Align Technology, Inc. - Biolase, Inc. - Danaher Corporation - Dentsply International, Inc. - Institut Straumann AG - Planmeca Oy - Sirona Dental Systems, Inc. - Zimmer Biomet Holdings, Inc Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Cosmetic Dentistry Market, By Product 8 Cosmetic Dentistry Market, By Region 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/zfmwlq/cosmetic
SIRO: 109.97 (-0.13), MMM: 178.36 (+0.38), ZBH: 131.14 (+3.67), ALGN: 89.15 (+3.87), BIOL: 1.13 (-0.03), DHR: 81.44 (+0.26)
Dental Lasers Market - Global Forecast to 2020
M2 - Fri Dec 04, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/xckzhj/dental_lasers) has announced the addition of the "Dental Lasers Market - Global Forecast to 2020" report to their offering. The global dental lasers market is expected to reach USD 224.7 million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The increasing awareness for oral hygiene; rising middle class and aging population; and rising demand for cosmetic dentistry, reduced treatment time, and operating cost have influenced the growth of the dental lasers market. The soft tissue dental lasers segment accounted for the largest share of the global dental lasers market in 2014. Soft tissue lasers are used to sterilize endodontic canals and treat periodontal disease as well as in tooth whitening procedures. The soft tissue dental laser segment dominated the market, owing to the increased number of cases of gingivectomy and periodontal diseases, among others. North America dominated the dental lasers market, due to the increasing technological advancements, growing awareness with respect to oral hygiene, and rising adoption rate of newer technologies in the region. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, due to factors such as the rise in the awareness of dental lasers, increased number aesthetic procedures, and rise in aging population. Reasons to Buy the Report: From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Industry Trends 5 Market Overview 6 Dental Lasers Market, By Product 7 Dental Lasers Market, By Application 8 Dental Lasers Market, By End User 9 Dental Lasers Market, By Geography 10 Competitive Landscape 11 Company Profiles - AMD Lasers - Biolase, Inc. - CAO Group, Inc. - Convergent Dental, Inc. - Danaher Corporation- Kavo Dental Gmbh - Fotona D.D. - Ivoclar Vivadent AG - Millennium Dental Technologies, Inc. - Sirona Dental Systems, Inc. - Syneron Dental Lasers-Syneron Medical Ltd. - The Yoshida Dental Mfg. Co., Ltd. - Zolar Technology & Mfg. Co. Inc. For more information visit http://www.researchandmarkets.com/research/xc...tal_lasers
ELOS: 7.37 (-0.03), SIRO: 109.97 (-0.13), BIOL: 1.13 (-0.03), DHR: 81.44 (+0.26)
BIOLASE Reports 2015 Third Quarter Results
BusinessWire - Wed Nov 04, 3:05PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the third quarter and nine months ended September 30, 2015.
BIOL: 1.13 (-0.03)
BIOLASE Announces Upgrade of Its Market-Leading WaterLase iPlus 2.0 Dental Laser to Treat Peri-implantitis
BusinessWire - Mon Nov 02, 5:00AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today an upgrade of its WaterLase iPlus(R) 2.0 dental laser to provide dental practitioners a clinical protocol and application to assist in the effective management of peri-implantitis. A growing problem in dentistry, peri-implantitis is a destructive inflammatory process affecting the soft and hard tissues surrounding dental implants.
BIOL: 1.13 (-0.03)
Shawn Cline Tomasello and Benjamin Wolin appointed to Diplomat Board of Directors
PR Newswire - Tue Oct 06, 2:29PM CDT
Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced the appointment of Shawn Cline Tomasello and Benjamin Wolin to the board of directors on Oct. 06, 2015. Ms. Tomasello and Mr. Wolin's appointment as independent directors meets the requirements of the New York Stock Exchange, and they will join the following members of Diplomat's board of directors to maintain the number of seven directors: Phil R. Hagerman, Diplomat chairman and CEO; Sean M. Whelan, director and chief financial officer of Diplomat; Gary W. Kadlec, director and president of Diplomat; David C. Dreyer, independent director and chief financial officer of BIOLASE, Inc., and Kenneth Klepper, independent director and past president and chief operating officer of Medco Health Solutions, Inc. Concurrently, Mr. Wolin was appointed to the Audit Committee of the board and Gary Kadlec, Diplomat's president and a board director, resigned from such Committee.
DPLO: 35.93 (-0.17), BIOL: 1.13 (-0.03)
BIOLASE Reports 2015 Second Quarter Results
BusinessWire - Wed Aug 05, 3:05PM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the second quarter and six months ended June 30, 2015.
BIOL: 1.13 (-0.03)
BIOLASE Reports 2016 Second Quarter and Six-Month Results
BusinessWire - 2 hrs 9 mins ago
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the second quarter and six months ended June 30, 2016.
BIOL: 1.13 (-0.03)
BIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement
BusinessWire - 2 hrs 19 mins ago
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that investors, including the Jack W. Schuler Living Trust, Oracle Partners, L.P. and Oracle Institutional Partners L.P., and certain BIOLASE directors and officers, have agreed to purchase $10 million of unregistered shares of the Company's convertible preferred stock, and related warrants to purchase unregistered shares of the Company's common stock, in a private placement transaction.
BIOL: 1.13 (-0.03)
BIOLASE(R) to Host 2016 Second Quarter Financial Results Conference Call on August 1
BusinessWire - Mon Jul 25, 5:00AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, August 1, 2016 at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter and six months ended June 30, 2016, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.
BIOL: 1.13 (-0.03)
BIOLASE to Present at the LD Micro Invitational
ACCESSWIRE - Wed Jun 01, 5:00AM CDT
LOS ANGELES, CA / ACCESSWIRE / June 1, 2016 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 6th annual LD Micro Invitational investor conference in Track 1 at 12:30 PM PDT, Wednesday, June 8, 2016. BIOLASE Senior Vice President and Chief Financial Officer David Dreyer will be giving the presentation and meeting with investors.
BIOL: 1.13 (-0.03)
Biolase reports 1Q loss
Automated Insights - Mon May 09, 4:02PM CDT
IRVINE, Calif. (AP) _ Biolase Inc. (BIOL) on Monday reported a loss of $4.3 million in its first quarter.
BIOL: 1.13 (-0.03)
BIOLASE Reports 2016 First Quarter Results
BusinessWire - Mon May 09, 3:05PM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the first quarter ended March 31, 2016.
BIOL: 1.13 (-0.03)
BIOLASE(R) to Host 2016 First Quarter Financial Results Conference Call on May 9, 2016
BusinessWire - Mon May 02, 5:00AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, May 9, 2016 at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2016, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.
BIOL: 1.13 (-0.03)
BIOLASE Reports 2015 Fourth Quarter and Year-End Results
BusinessWire - Wed Mar 09, 3:05PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the fourth quarter and year ended December 31, 2015.
BIOL: 1.13 (-0.03)
BIOLASE signs dental laser products development agreement with IPG Photonics
M2 - Thu Jan 14, 7:30AM CST
Dental lasers company BIOLASE (NasdaqCM:BIOL) revealed on Wednesday that it has entered into a development and distribution agreement with IPG Medical for dental laser products.
BIOL: 1.13 (-0.03), IPGP: 84.29 (+0.04)
BIOLASE Enters Into Development Agreement with IPG Photonics
BusinessWire - Tue Jan 12, 3:05PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it recently entered into a development and distribution agreement with IPG Photonics Corporation's medical laser division, IPG Medical.
BIOL: 1.13 (-0.03), IPGP: 84.29 (+0.04)
Refractive Surgery Devices Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Wed Dec 23, 6:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/d7svhj/refractive) has announced the addition of the "Refractive Surgery Devices - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Refractive Surgery Devices pipeline products. Key Topics Covered: - Extensive coverage of the Refractive Surgery Devices under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Refractive Surgery Devices and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Refractive Surgery Devices under development - Develop market-entry and market expansion strategies Companies Mentioned: - Alcon, Inc. - Avedro, Inc. - Belkin Laser Ltd - Biolase, Inc. - Carl Zeiss Meditec AG - CV Laser Pty Ltd - IFS Construction Services Ltd - Lensar, Inc. - Massachusetts Eye and Ear Infirmary - Nidek Co., Ltd. - Oraya Therapeutics, Inc. - Princeton University - Rowiak GmbH - Spire Corporation - STAAR Surgical Company - Stroma Medical Corp - Technolas Perfect Vision GmbH (Inactive) - University of Bern - University of Calgary - Visioneering Technologies, Inc. - Wake Forest Baptist Medical Center Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Refractive Surgery Devices - Pipeline Products under Development by Companies 5 Refractive Surgery Devices Companies and Product Overview 6 Refractive Surgery Devices- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/d7svhj/refractive
STAA: 6.84 (+0.08), BIOL: 1.13 (-0.03)
World Cosmetic Dentistry Market 2015-2020 - Dental Implants, Bridges, Crowns, Orthodontic Braces, Lasers, Veneers, Handpieces, Bonding Agents, Chairs & CAD/CAM
M2 - Mon Dec 07, 5:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/zfmwlq/cosmetic) has announced the addition of the "Cosmetic Dentistry Market by Product (Dental Implants, Dental Bridges, Dental Crowns, Orthodontic Braces, Dental Lasers, Dental Veneers, Dental Handpieces, Bonding Agents, Dental Lasers, Dental Chairs, CAD/CAM Systems) - Global Forecast to 2020" report to their offering. The Global Cosmetic Dentistry Market is Estimated to Grow at a CAGR of 6.8% from 2015 to 2020 to Reach USD 22.4 Billion by 2020 Growing consumer awareness, rising focus on dental aesthetics, expanding middle-class population with increasing disposable incomes in developing nations, and rising dental tourism in emerging markets are the major factors driving the growth of the cosmetic dentistry market. With rising focus on technological innovations and the increasing trend of R&D investments, various new products such as dental implants and equipment are being launched in Cosmetic Dentistry market, which are expected to further propel market growth. However, a lack of reimbursements for cosmetic dental procedures and the high cost of dental imaging systems could restrain the growth of this market during the forecast period. In this report, the cosmetic dentistry market is segmented on the basis of product and region. On the basis of products, Cosmetic Dentistry market is segmented into dental implants, dental bridges, dental crowns, dental veneers, dental systems and equipment, orthodontic braces, bonding agents, and inlays and onlays. Of these, the dental systems and equipment market accounted for the largest share in 2014, owing to the wide applications of dental equipment such as dental chairs, handpieces, and CAD/CAM systems in dental procedures. Geographically, the global cosmetic dentistry market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2014, Europe commanded a major share of the cosmetic dentistry market; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to improvements in healthcare infrastructure, rising disposable incomes, and increasing dental tourism in this region. Some prominent players in this market include - 3M Company - A-Dec Inc. - Align Technology, Inc. - Biolase, Inc. - Danaher Corporation - Dentsply International, Inc. - Institut Straumann AG - Planmeca Oy - Sirona Dental Systems, Inc. - Zimmer Biomet Holdings, Inc Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Cosmetic Dentistry Market, By Product 8 Cosmetic Dentistry Market, By Region 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/zfmwlq/cosmetic
SIRO: 109.97 (-0.13), MMM: 178.36 (+0.38), ZBH: 131.14 (+3.67), ALGN: 89.15 (+3.87), BIOL: 1.13 (-0.03), DHR: 81.44 (+0.26)
Dental Lasers Market - Global Forecast to 2020
M2 - Fri Dec 04, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/xckzhj/dental_lasers) has announced the addition of the "Dental Lasers Market - Global Forecast to 2020" report to their offering. The global dental lasers market is expected to reach USD 224.7 million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The increasing awareness for oral hygiene; rising middle class and aging population; and rising demand for cosmetic dentistry, reduced treatment time, and operating cost have influenced the growth of the dental lasers market. The soft tissue dental lasers segment accounted for the largest share of the global dental lasers market in 2014. Soft tissue lasers are used to sterilize endodontic canals and treat periodontal disease as well as in tooth whitening procedures. The soft tissue dental laser segment dominated the market, owing to the increased number of cases of gingivectomy and periodontal diseases, among others. North America dominated the dental lasers market, due to the increasing technological advancements, growing awareness with respect to oral hygiene, and rising adoption rate of newer technologies in the region. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, due to factors such as the rise in the awareness of dental lasers, increased number aesthetic procedures, and rise in aging population. Reasons to Buy the Report: From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Industry Trends 5 Market Overview 6 Dental Lasers Market, By Product 7 Dental Lasers Market, By Application 8 Dental Lasers Market, By End User 9 Dental Lasers Market, By Geography 10 Competitive Landscape 11 Company Profiles - AMD Lasers - Biolase, Inc. - CAO Group, Inc. - Convergent Dental, Inc. - Danaher Corporation- Kavo Dental Gmbh - Fotona D.D. - Ivoclar Vivadent AG - Millennium Dental Technologies, Inc. - Sirona Dental Systems, Inc. - Syneron Dental Lasers-Syneron Medical Ltd. - The Yoshida Dental Mfg. Co., Ltd. - Zolar Technology & Mfg. Co. Inc. For more information visit http://www.researchandmarkets.com/research/xc...tal_lasers
ELOS: 7.37 (-0.03), SIRO: 109.97 (-0.13), BIOL: 1.13 (-0.03), DHR: 81.44 (+0.26)
BIOLASE Reports 2015 Third Quarter Results
BusinessWire - Wed Nov 04, 3:05PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the third quarter and nine months ended September 30, 2015.
BIOL: 1.13 (-0.03)
BIOLASE Announces Upgrade of Its Market-Leading WaterLase iPlus 2.0 Dental Laser to Treat Peri-implantitis
BusinessWire - Mon Nov 02, 5:00AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today an upgrade of its WaterLase iPlus(R) 2.0 dental laser to provide dental practitioners a clinical protocol and application to assist in the effective management of peri-implantitis. A growing problem in dentistry, peri-implantitis is a destructive inflammatory process affecting the soft and hard tissues surrounding dental implants.
BIOL: 1.13 (-0.03)
Shawn Cline Tomasello and Benjamin Wolin appointed to Diplomat Board of Directors
PR Newswire - Tue Oct 06, 2:29PM CDT
Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced the appointment of Shawn Cline Tomasello and Benjamin Wolin to the board of directors on Oct. 06, 2015. Ms. Tomasello and Mr. Wolin's appointment as independent directors meets the requirements of the New York Stock Exchange, and they will join the following members of Diplomat's board of directors to maintain the number of seven directors: Phil R. Hagerman, Diplomat chairman and CEO; Sean M. Whelan, director and chief financial officer of Diplomat; Gary W. Kadlec, director and president of Diplomat; David C. Dreyer, independent director and chief financial officer of BIOLASE, Inc., and Kenneth Klepper, independent director and past president and chief operating officer of Medco Health Solutions, Inc. Concurrently, Mr. Wolin was appointed to the Audit Committee of the board and Gary Kadlec, Diplomat's president and a board director, resigned from such Committee.
DPLO: 35.93 (-0.17), BIOL: 1.13 (-0.03)
BIOLASE Reports 2015 Second Quarter Results
BusinessWire - Wed Aug 05, 3:05PM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the second quarter and six months ended June 30, 2015.
BIOL: 1.13 (-0.03)
